Camber Pharma Launches Generic Combivir®
Piscataway, NJ, September 20, 2014– Camber Pharmaceuticals announces that it has launched Lamivudine/Zidovudine, USP 150 mg/300mg tablets. The drug is the generic version of Combivir® tablets.
Lamivudine/Zidovudine is available only in 60 count bottle.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year